RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept
  • Home
  • Impact
  • Publications
  • Direct costs to private insurers of diversion of medications for attention-deficit/hyperactivity disorder

Direct costs to private insurers of diversion of medications for attention-deficit/hyperactivity disorder

Aldridge, A., Kroutil, L., Cowell, A., Reeves, D., & Van Brunt, D. (2011). Direct costs to private insurers of diversion of medications for attention-deficit/hyperactivity disorder. PharmacoEconomics, 29(7)(1170-7690), 621 - 635.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Meet the Experts

View All Experts
Alexander Cowell

Alexander Cowell
arnie aldridge

Arnie Aldridge
Larry Kroutil

Larry Kroutil

Recent Publications

Article

The evolution of minimally invasive tissue sampling in postmortem examination
Article

Community engagement to implement evidence-based practices in the HEALing Communities Study
Article

Cannabinoid receptor subtype influence on neuritogenesis in human SH-SY5Y cells
Article

Operationalizing and selecting outcome measures for the HEALing Communities Study